Second-line treatments after FOLFIRINOX or gemcitabine plus nab-paclitaxel failure for unresectable pancreatic cancer under real-life clinical conditions: Experience at a single institute
Okano, Naohiro, Kawai, Kirio, Naruge, Daisuke, Nagashima, Fumio, Furuse, JunjiVolume:
16
Language:
english
Journal:
Pancreatology
DOI:
10.1016/j.pan.2016.06.622
Date:
August, 2016
File:
PDF, 62 KB
english, 2016